Back
Supernus Pharmaceuticals Stock Predictions
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
SUPN
Supernus Pharmaceuticals
Last Price:
$32.19
Seasonality Move:
12.87%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Supernus Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 23.1% based on the past 12 years of stock performance.
-
Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Supernus Pharmaceuticals Stock Undervalued?The current Supernus Pharmaceuticals [SUPN] share price is $31.35. The Score for SUPN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
SUPN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 23.1% based on the past 12 years of stock performance.
Supernus Pharmaceuticals Stock Rating
Buy
53
Supernus Pharmaceuticals (SUPN)
is a Buy
Is Supernus Pharmaceuticals overpriced?
-
Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Supernus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
40.28
52-Week Low:
25.53
Prediction Charts
Market Cap:
1.7B
Price in USD:
31.35
Volume:
277.9K
Beta:
1.09
Technical Analysis
SMA50:
32.80
SMA100:
35.07
SMA200:
33.80
52-Wk Change:
3.6%
Stock Predictions
-
Is Supernus Pharmaceuticals stock public?Yes, Supernus Pharmaceuticals is a publicly traded company.
-
What is the Supernus Pharmaceuticals stock quote today?The Supernus Pharmaceuticals stock price is 31.35 USD today.
-
How to buy Supernus Pharmaceuticals stock online?You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-7 | 32.15 | 32.27 | 34.26 | 31.97 |
| Apr-8 | 32.75 | 30.64 | 33.14 | 30.24 |
| Apr-9 | 30.00 | 31.76 | 32.05 | 29.77 |
| Apr-10 | 31.37 | 31.07 | 31.55 | 30.11 |
| Apr-11 | 31.23 | 31.67 | 31.68 | 30.60 |
| Apr-14 | 31.98 | 31.60 | 32.28 | 31.42 |
| Apr-15 | 31.95 | 31.46 | 32.28 | 31.21 |
| Apr-16 | 32.10 | 30.71 | 32.10 | 30.59 |
| Apr-17 | 30.68 | 30.76 | 31.15 | 30.52 |
| Apr-21 | 30.49 | 30.29 | 31.06 | 29.87 |
| Apr-22 | 31.70 | 30.84 | 31.70 | 30.24 |
| Apr-23 | 31.31 | 30.84 | 31.64 | 30.67 |
| Apr-24 | 30.84 | 31.35 | 31.45 | 30.42 |
| Apr-25 | 31.41 | 32.22 | 32.36 | 31.16 |
Supernus Pharmaceuticals Earnings
Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals Forecast Revenue Growth
Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.89 per share, and an increase next year of $0.56 per share.
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.